Assignee
PORTOLA PHARM INC
US·49 granted patents·43 pending applications·363 citations·filing 1999–2020
Top patents by PatentIndex Score
92 records- 0195US9388401B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Granted Jul 12, 2016·18 cites·19 claims
- 0295US9062298B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Jun 23, 2015·21 cites·18 claims
- 0395US8889129B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Nov 18, 2014·18 cites·22 claims
- 0494US8937070B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2013·Granted Jan 20, 2015·16 cites·7 claims
- 0594US8349860B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2011·Granted Jan 8, 2013·9 cites·2 claims
- 0693US11028382B2Lyophilized formulations for factor Xa antidotePORTOLA PHARM INC·Filed 2020·Granted Jun 8, 2021·3 cites·9 claims
- 0793US9587233B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2015·Granted Mar 7, 2017·10 cites·7 claims
- 0892US9868729B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Jan 16, 2018·12 cites·12 claims
- 0992US8952027B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2012·Granted Feb 10, 2015·6 cites·21 claims
- 1092US8853230B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2012·Granted Oct 7, 2014·19 cites·14 claims
- 1192US7705004B2Protein kinase inhibitorsPORTOLA PHARM INC·Filed 2008·Granted Apr 27, 2010·22 cites·17 claims
- 1292US6906063B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2001·Granted Jun 14, 2005·34 cites·8 claims
- 1391US10675335B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Granted Jun 9, 2020·3 cites·3 claims
- 1491US7022731B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2004·Granted Apr 4, 2006·22 cites·12 claims
- 1590US10765726B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
- 1690US7358091B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2005·Granted Apr 15, 2008·23 cites·14 claims
- 1789US6689786B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2003·Granted Feb 10, 2004·24 cites·13 claims
- 1888US10533001B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2017·Granted Jan 14, 2020·4 cites·13 claims
- 1988US8367689B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2010·Granted Feb 5, 2013·11 cites·27 claims
- 2087US8877760B2Substituted pyrazine-2-carboxamide kinase inhibitorsPORTOLA PHARM INC·Filed 2012·Granted Nov 4, 2014·8 cites·5 claims
- 2187US7678913B2Ureas as factor Xa inhibitorsPORTOLA PHARM INC·Filed 2005·Granted Mar 16, 2010·9 cites·34 claims
- 2286US10190111B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Jan 29, 2019·3 cites·10 claims
- 2386US7358257B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2005·Granted Apr 15, 2008·7 cites·10 claims
- 2485US10736895B2Cerdulatinib for treating hematological cancersPORTOLA PHARM INC·Filed 2016·Granted Aug 11, 2020·3 cites·24 claims
- 2585US7834023B2Substituted dihydroquinazolines as platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2007·Granted Nov 16, 2010·4 cites·26 claims
- 2684US7785891B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2008·Granted Aug 31, 2010·10 cites·11 claims
- 2783US9676756B2Substituted pyrimidinyl kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Jun 13, 2017·6 cites·23 claims
- 2883US9359375B2Benzamides and nicotinamides as Syk modulatorsPORTOLA PHARM INC·Filed 2014·Granted Jun 7, 2016·5 cites·15 claims
- 2982US10865198B2Solid forms of cerdulatinibPORTOLA PHARM INC·Filed 2019·Granted Dec 15, 2020·3 cites·40 claims
- 3082US10604748B2Preparation of factor Xa derivativesPORTOLA PHARM INC·Filed 2017·Granted Mar 31, 2020·3 cites·27 claims
- 3176US10851087B2Synthesis of cerdulatinibPORTOLA PHARM INC·Filed 2019·Granted Dec 1, 2020·1 cites·41 claims
- 3276US9533986B2Bicyclic dihydropyridone kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Jan 3, 2017·3 cites·18 claims
- 3376US9469654B2Bicyclic oxa-lactam kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Oct 18, 2016·3 cites·20 claims
- 3475US7205296B2Substituted 2H-1,3-benzoxazin-4(3H)-onesPORTOLA PHARM INC·Filed 2005·Granted Apr 17, 2007·2 cites·27 claims
- 3574US7056926B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2004·Granted Jun 6, 2006·4 cites·20 claims
- 3671US2019127720A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 3771US2021085762A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2020·Application pending·0 cites
- 3870US9579320B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Feb 28, 2017·0 cites·3 claims
- 3969US7294635B2Substituted isoquinolinonesPORTOLA PHARM INC·Filed 2004·Granted Nov 13, 2007·4 cites·30 claims
- 4068US2011212983A1Platelet adp receptor inhibitorsPORTOLA PHARM INC·Filed 2009·Application pending·0 cites
- 4167US2018320160A1Lyophilized formulations for factor xa antidotePORTOLA PHARM INC·Filed 2017·Application pending·0 cites
- 4266US2017240879A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 4366US2020129597A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2019·Application pending·0 cites
- 4465US2013230901A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 4565US2017014492A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 4663US7622474B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2007·Granted Nov 24, 2009·0 cites·8 claims
- 4763US2015352194A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 4863US2015376592A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2015·Application pending·0 cites
- 4963US2015025011A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Application pending·0 cites
- 5063US2018333469A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PORTOLA PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →